Products & ReviewLife Sciences

Olink® Target 96 Inflammation

The most comprehensive, high-performance protein biomarker panel available for inflammation studies.

Olink Proteomics

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review
Description

Our Inflammation panel provides a high-throughput, multiplex immunoassay enabling analysis of 92 inflammation-related protein biomarkers across 96 samples simultaneously. This high level of multiplexing is achieved without any compromise on data quality, thanks to our proprietary Proximity Extension Assay (PEA) technology.

This represents the most extensive panel available on the market for proteins associated with inflammatory diseases and related biological processes, enabling investigation of protein signatures with high efficiency and robustness and accelerates the speed of finding new and relevant human protein biomarkers related to inflammation. The panel is compiled to detect a selection of already established as well as exploratory biomarkers within the inflammation research field. The content of the panel has been designed in close collaboration with experts within various disease areas such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, neuro inflammation, and respiratory diseases, and it is well suited to discerning protein profiles in clinically relevant samples.

  • High quality data that you can trust
  • The rapid high throughput analysis that your studies deserve
  • The most effective use of your precious samples (1 µL blood to measure 92 proteins)

The panel is available via fee-for-service analysis, or as a reagent kit (requires a Fludigm® Biomark qPCR instrument to run).

White PapersLife Sciences

Revealing previously inaccessible protein insights from minimal sample volume

Discover the ultimate tool for multiplex protein analysis of precious samples. This white paper provides an overview of how Olink's proximity extension assay (PEA) technology has been used to measure 10s to 1000s of protein biomarkers from minute volumes of precious samples across major research areas, while delivering high data quality and robust performance.



‘Our customers are our heroes’ says Scientists’ Choice Award winner Olink Proteomics

This year’s Scientists’ Choice Award for Drug Discovery & Development Article of the Year went to an interview with Prof. Leo A. B Joosten, Radboudumc, detailing how Olink Proteomics multiplex immunoassay technology enabled identification of biomarkers to predict patient risk of COVID-19.

In this video, Dr. Andrea Ballagi, VP Sales and Marketing, Olink Proteomics, shares her thoughts on winning this prized award, why promoting customer success is important for Olink Proteomics and the scientific community, and how the company’s technology will help advance future drug discovery.

Read the winning article here: Clinical proteomics: Identifying biomarkers to predict patient risk of COVID-19

Product Overview

Links

Buy Olink® Target 96 Inflammation Read Reviews